Which pharmaceutical company first introduced the 'accelerated access pathway' marketing model that allowed terminal patients to access experimental drugs before FDA approval?

The pharmaceutical and medical device industries invest billions in developing innovative products each year. Marketing these breakthroughs often involves unique strategies to gain physician and patient trust. This trivia question explores a groundbreaking product development approach that changed how medical innovations reach consumers. Test your knowledge of medical product development history!

This is a live public trivia poll on AIPolls.Net. Vote and see real-time results.

Genentech with their 'Compassionate Use Program' for cancer treatments in 1992
Pfizer with their 'Early Patient Access' initiative for HIV medications in 1995
Johnson & Johnson with their 'Breakthrough Therapy' platform for immunotherapies in 2001
Merck with their 'Right to Try' protocol for rare disease treatments in 1988